• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>JEMDSA: Journal of Endocrinology, Metabolism and Diabetes of South Africa (JEMSDA) : The Official Journal of the Society of Endocrinology, Metabolism, and Diabetes of South Africa >Pulmonary hypertension and thyrotoxicosis
【24h】

Pulmonary hypertension and thyrotoxicosis

机译：肺动脉高压和甲状腺毒症

获取原文
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Thyrotoxicosis is listed as a cause of pulmonary arterial hypertension (PAH). The aetiopathogenesis remains largely uncertain, but an autoimmune mechanism has been postulated, among others. In this setting, other causes of PAH need to be actively sought and excluded prior to attributing it to the thyrotoxicosis. The importance of recognising this condition is that it is usually reversible with restoration of a euthyroid state. We describe three patients who presented with thyrotoxicosis and features of PAH in whom other causes were excluded with various investigations. We also demonstrated reversibility of the pulmonary hypertension upon restoration of a normal thyroid state.
机译：甲状腺毒症被列为肺动脉高压（PAH）的原因。致病机理在很大程度上仍不确定，但是除其他外，已经假定了自身免疫机制。在这种情况下，在将PAH归因于甲状腺毒症之前，需要积极寻找和排除PAH的其他原因。认识到这种情况的重要性在于，它通常可以随着甲状腺功能正常状态的恢复而逆转。我们描述了三例表现为甲状腺毒症和PAH特征的患者，其中通过其他调查排除了其他原因。我们还证实了恢复正常甲状腺状态后肺动脉高压的可逆性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号